Ocular metastases from HER2 positive breast carcinoma and the response to combination therapy with Paclitaxel and Trastuzumab: a case report

PURPOSE: Breast cancer is the most common tumour to metastasize to the uveal tract. The mean survival period after diagnosis of metastasis to the eye, ranges from 10 to 32 months. However, recent advances in therapy including the use of monoclonal antibody therapy, will hopefully improve treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Konstantinos I, Sinha, Ajay, Ioannidis, Alexander S, Davidson, Neville G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803940/
https://www.ncbi.nlm.nih.gov/pubmed/20062660
http://dx.doi.org/10.1186/1757-1626-2-9143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803940/
https://www.ncbi.nlm.nih.gov/pubmed/20062660
http://dx.doi.org/10.1186/1757-1626-2-9143

Ejemplares similares